World CDx 2026 has ended. This guide stays up as the record of who was there. Next: World CDx 2027, Aug 30 – Sep 2, 2027 in Boston
Gilead Sciences at World CDx 2026
Oct 5–8, 2026 Boston, MA ~900 attendees Website
Gilead Sciences takes part in 3 sessions at World CDx 2026 in Boston. Its sessions center on AI-based tissue pathology as a source of new biomarkers beyond immunohistochemistry scoring. Most concrete are the promise and pitfalls of measuring tumor target levels when developing antibody-drug conjugates and immune cell engagers.
| Organization | World CDx 2026 Attendance |
|---|---|
Gilead Sciences Foster City, CA | |
Biopharmaceutical company with marketed medicines in HIV, liver disease, oncology and inflammation, including antibody-drug conjugates and CAR T therapies. | Panel Wed Oct 7 11:20am Beyond the Slide: Tissue AI as the Anchor for Multimodal Biomarker Discovery & Global Deployment Digital pathology & spatial biomarkersMultimodal & AI-enabled precision medicine Panel Wed Oct 7 2:10pm Beyond IHC Scoring: Unlocking Next-Generation Clinical Biomarkers through AI-Powered Computational Pathology Digital pathology & spatial biomarkersMultimodal & AI-enabled precision medicine Talk Wed Oct 7 2:40pm Promise & Pitfalls of Tumor Target Quantification in Antibody-Drug Conjugate & Immune Cell Engager Drug Development Biomarker discovery & translationDigital pathology & spatial biomarkers |
Instantly find 20 buyers from Gilead Sciences
Get a list of who you should contact, their contact info, and what to say.
Totally free and instant, no sign up necessary!
Not affiliated with or endorsed by World CDx or its organizers. Submit a correction